Gene · 5281
Papers2,279
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
361 to 380 of 2,279
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
A cellular senescence-related classifier based on a tumorigenesis- and immune infiltration-guided strategy can predict prognosis, immunotherapy response, and candidate drugs in hepatocellular carcinoma. | Front Immunol | 2022 | 36458010 | PubTator, text mining | PubMed |
| Manipulation of the crosstalk between tumor angiogenesis and immunosuppression in the tumor microenvironment: Insight into the combination therapy of anti-angiogenesis and immune checkpoint blockade. | Front Immunol | 2022 | 36439137 | PubTator, text mining | PubMed |
| Pravastatin and placental insufficiency associated disorders: A systematic review and meta-analysis. | Front Pharmacol | 2022 | 36438820 | PubTator, text mining | PubMed |
| Inflammatory Response in Oral Biofilm during Pregnancy: A Systematic Review. | Nutrients | 2022 | 36432584 | PubTator, text mining | PubMed |
| Endothelial-Specific Molecule 1 Inhibition Lessens Productive Angiogenesis and Tumor Metastasis to Overcome Bevacizumab Resistance. | Cancers (Basel) | 2022 | 36428773 | PubTator, text mining | PubMed |
| Identification of vascular endothelial growth factor in preeclampsia in Iraqi women. | J Med Life | 2022 | 36420291 | PubTator, text mining | PubMed |
| Peripheral blood cytokines as potential diagnostic biomarkers of suicidal ideation in patients with first-episode drug-naïve major depressive disorder. | Front Public Health | 2022 | 36420006 | PubTator, text mining | PubMed |
| Hydroxychloroquine reduces soluble Flt-1 secretion from human cytotrophoblast, but does not mitigate markers of endothelial dysfunction in vitro. | PLoS One | 2022 | 36417467 | PubTator, text mining | PubMed |
| Tumor-associated macrophages promote resistance of hepatocellular carcinoma cells against sorafenib by activating CXCR2 signaling. | J Biomed Sci | 2022 | 36411463 | PubTator, text mining | PubMed |
| COVID-19 associated liver injury: A general review with special consideration of pregnancy and obstetric outcomes. | World J Gastroenterol | 2022 | 36405386 | PubTator, text mining | PubMed |
| Dynamic gestational week prediction model for pre-eclampsia based on ID3 algorithm. | Front Physiol | 2022 | 36388117 | PubTator, text mining | PubMed |
| Comparison of serum cytokines levels in normal-weight and overweight patients with first-episode drug-naïve major depressive disorder. | Front Endocrinol (Lausanne) | 2022 | 36387880 | PubTator, text mining | PubMed |
| Identification of Hypoxia-Related Prognostic Signature and Competing Endogenous RNA Regulatory Axes in Hepatocellular Carcinoma. | Int J Mol Sci | 2022 | 36362375 | PubTator, text mining | PubMed |
| Expression of Matrix Metalloproteinase-2,-7,-9 in Serum during Pregnancy in Patients with Pre-Eclampsia: A Prospective Study. | Int J Environ Res Public Health | 2022 | 36361378 | PubTator, text mining | PubMed |
| Early Diagnosis of Chemotherapy-Linked Cardiotoxicity in Breast Cancer Patients Using Conventional Biomarker Panel: A Prospective Study Protocol. | Diagnostics (Basel) | 2022 | 36359556 | PubTator, text mining | PubMed |
| Current and Novel Therapeutic Approaches for Treatment of Neovascular Age-Related Macular Degeneration. | Biomolecules | 2022 | 36358978 | PubTator, text mining | PubMed |
| Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia. | Sci Rep | 2022 | 36351970 | PubTator, text mining | PubMed |
| Modification of mesenchymal stem cells for cartilage-targeted therapy. | J Transl Med | 2022 | 36348497 | PubTator, text mining | PubMed |
| Preclinical models of radiation-induced cardiac toxicity: Potential mechanisms and biomarkers. | Front Oncol | 2022 | 36313656 | PubTator, text mining | PubMed |
| Current and emerging anti-angiogenic therapies in gastrointestinal and hepatobiliary cancers. | Front Oncol | 2022 | 36300092 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5281/papers?page=19